Ledger.Open graph →
SEC Form D · filed October 16, 2024

Lexaria Bioscience Corp

Offering
$5.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
KELOWNA, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Ted Mckechnie · Kelowna, British Columbia, CanadaDirectorRichard Christopher · Kelowna, British Columbia, CanadaExec · DirectorNicholas Baxter · Kelowna, British Columbia, CanadaDirectorMichael Shankman · Kelowna, British Columbia, CanadaExecCatherine Turkel · Kelowna, British Columbia, CanadaDirectorAlbert E. Reese · Kelowna, British Columbia, CanadaDirectorChristopher Bunka · Kelowna, British Columbia, CanadaDirectorTed Mckechnie · Kelowna, British Columbia, CanadaDirectorJohn Docherty · Kelowna, British Columbia, CanadaExec · DirectorRichard Christopher · Kelowna, British Columbia, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗